Can a Pre-Surgery boost help pancreatic cancer patients recover faster?

NCT ID NCT07478185

Recruiting now Symptom relief Sponsor: University of Massachusetts, Worcester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether a structured program of exercise, nutrition counseling, and support—called prehabilitation—can help adults with pancreatic cancer get stronger before surgery. Twenty participants will follow the program while receiving chemotherapy before their operation. The goal is to see if patients can stick with the program and whether it improves physical function and recovery after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multimodal prehabilitation (exercise, nutrition counseling, immunonutrition, and supportive care)
What this could lead to: If this program works, it could help patients feel stronger and recover faster after pancreatic cancer surgery.
What could go wrong: This is a very small pilot study with only 20 participants, so results may not apply to everyone. The program requires significant effort and may not be feasible for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm Pancreatic cancer, adult pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER, ADULT PREHABILITATION

Contacts and locations

Locations

UMass Memorial Medical Center
RECRUITING

Worester, Massachusetts, 01655, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.